Press Release

View printer-friendly version

<<  Back

Streamline Health® Reports First Quarter 2015 Revenues Of $6.2 Million; Recurring Revenues Of 93%

ATLANTA, June 9, 2015 /PRNewswire/ -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of transformational data-driven solutions to help healthcare providers reduce exposure to risk, enhance clinical, financial, and operational performance, and improve patient care, today announced financial results for the first quarter of 2015, which ended April 30, 2015.

Revenues for the three-month period ended April 30, 2015 decreased approximately 11% to $6.2 million versus $7.0 million in the comparable period of fiscal 2014. Adjusted EBITDA for the first quarter was $(1.3) million, down from $(0.5) million in the same period a year ago.

"While revenues for the first quarter declined from year ago period primarily due to the run rate impact of the previously discussed client attrition we experienced during fiscal year 2014, our solid bookings in Q1 has pushed our backlog to nearly $75 million. Today our committed, unimplemented quarterly recurring revenue stands at approximately $1.1 million, equating to nearly $4.5 million in annual revenues that are unrecognized at this time," stated David W. Sides, President and CEO, Streamline Health Solutions, Inc.  "Given the healthy sales activity we are experiencing early into our second quarter, we firmly believe that our first quarter performance will represent the bottom of the curve.  We believe that our key fundamentals will show improvement in the coming quarters, from continued solid bookings, to improving top line revenue growth, to cash on the balance sheet and reduction in our debt."

Highlights for the first quarter ended April 30, 2015 included:

  • Revenues for the first quarter 2015 were $6.2 million;
  • Adjusted EBITDA for the first quarter 2015 was $(1.3) million;
  • Recorded net loss of $(1.9) million for the three-month period ended April 30, 2015;
  • Maintenance and support revenues for the quarter decreased $0.5 million over the same period one year ago;
  • New sales bookings for the quarter were $6.4 million; and
  • Backlog at the end of the quarter was $74.6 million.

The Company will conduct a conference call to review the results on Tuesday, June 9, 2015 at 5:00 PM ET. Interested parties can access the call by dialing 888-572-7034 and then entering Conference ID 5377721. A live webcast will also be available; click here to register.

A replay of the conference call will be available from Tuesday, June 9, 2015 at 8:00 PM ET to Sunday, June 14, 2015 at 8:00 PM ET by dialing 888-203-1112 and entering passcode 5377721.

*Non-GAAP Financial Measures

Streamline Health reports its financial results in accordance with U.S. generally accepted accounting principles ("GAAP"). Streamline Health's management also evaluates and makes operating decisions using various other measures. One such measure is adjusted EBITDA, which is a non-GAAP financial measure. Streamline Health's management believes that this measure provides useful supplemental information regarding the performance of Streamline Health's business operations.

Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, and professional and advisory fees. A table illustrating this measure is included in this press release.

About Streamline Health
Streamline Health Solutions, Inc. (NASDAQ: STRM) is a healthcare industry leader in capturing, aggregating, and translating enterprise data into knowledge­ - actionable insights that reduce exposure to risk, enhance operational performance, and improve patient care. Through our Looking Glass® Platform we provide clients with meaningful, intelligent SaaS-based solutions from patient engagement to reimbursement. We share a common calling and commitment to advance the quality of life and the quality of healthcare -- for society, our industry, our clients, the communities they serve, and the individual patient. For more information, please visit our website at www.streamlinehealth.net.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
Statements made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks, uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding the Company's estimates of future revenue, cash position, debt, backlog, renewal sales, interoperability among the Company's solutions, new client sales, success of the Company's channel partner relationships and related expectations and assumptions.  These risks and uncertainties include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog, the impact of competitive solutions and pricing, solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors and channel partners that resell the Company's solutions, the ability of the Company to control costs, availability of solutions from third party vendors, the healthcare regulatory environment, potential changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets, availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, and the Company's ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's analysis only as of the date hereof. The Company undertakes no obligation to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Company Contact:
Randy Salisbury
SVP, Chief Marketing Officer
(404) 229-4242
randy.salisbury@streamlinehealth.net

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)




Three Months Ended



April 30,



2015


2014

Revenues:





  Systems sales

$

298,616

$

339,205

  Professional services


350,959


608,951

  Maintenance and support


3,654,065


4,171,812

  Software as a service


1,865,802


1,831,202

        Total revenues


6,169,442


6,951,170






Operating expenses:





  Cost of systems sales


726,791


835,468

  Cost of services


771,496


986,425

  Cost of maintenance and support


816,905


960,186

  Cost of software as a service


738,831


771,579

  Selling, general and administrative


4,506,174


4,640,456

  Research and development


2,224,193


2,350,443

        Total operating expenses


9,784,390


10,544,557

Operating loss


(3,614,948)


(3,593,387)

Other income (expense):





  Interest expense


(243,941)


(169,478)

  Miscellaneous income


1,988,974


1,092,771

Loss before income taxes


(1,869,915)


(2,670,094)

  Income tax expense


3,882


(1,145)

Net loss

$

(1,866,033)

$

(2,671,239)

Less: deemed dividends on Series A Preferred Shares


(295,657)


(229,766)

Net loss attributable to common shareholders

$

(2,161,690)

$

(2,901,005)

Basic net loss per common share

$

(0.12)

$

(0.16)

Number of shares used in basic per common share computation


18,600,957


18,146,232

Diluted net loss per common share

$

(0.12)

$

(0.16)

Number of shares used in diluted per common share computation


18,600,957


18,146,232

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


Assets




April 30,

2015


January 31,

2015






Current assets:





  Cash and cash equivalents

$

5,269,706

$

6,522,600

  Accounts receivable, net of allowance for doubtful





    accounts of $700,083 and $665,962, respectively


6,255,485


6,935,270

  Contract receivables


248,674


191,465

  Prepaid hardware and third party software for





    future delivery


30,978


55,173

  Prepaid client maintenance contracts


1,006,895


935,858

  Other prepaid assets


1,093,834


1,437,680

  Deferred income taxes


220,004


220,004

  Other current assets


114,052


207,673

        Total current assets


14,239,628


16,505,723






Non-current assets:





Property and equipment:





  Computer equipment


2,325,641


2,381,923

  Computer software


750,532


964,857

  Office furniture, fixtures and equipment


683,443


683,443

  Leasehold improvements


727,654


724,015



4,487,270


4,754,238

  Accumulated depreciation and amortization


(1,683,426)


(1,617,423)

Property and equipment, net


2,803,844


3,136,815






 Contract receivables, less current portion


34,842


43,553

 Capitalized software development costs, net of





   accumulated amortization of $12,628,936 and





   $11,846,468, respectively


8,414,650


9,197,118

Intangible assets, net of accumulated amortization of





   $3,663,913 and $3,326,683, respectively


9,163,087


9,500,317

Deferred financing costs, net of accumulated





   amortization of $31,330 and $13,677, respectively


323,349


387,199

Goodwill


16,184,667


16,184,667

Other


826,603


823,723

       Total non-current assets


37,751,042


39,273,392


$

51,990,670

$

55,779,115

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)


Liabilities and Stockholders' Equity




April 30,

2015


January 31,

2015






Current liabilities:





   Accounts payable

$

1,718,689

$

2,298,851

   Accrued compensation


511,946


865,865

   Accrued other expenses


779,523


563,838

   Current portion of long-term debt


562,500


500,000

   Deferred revenues


8,587,107


9,289,076

   Current portion of capital lease obligation


766,442


781,961

      Total current liabilities


12,926,207


14,299,591






Non-current liabilities:





   Term loans


9,312,500


9,500,000

   Warrants liability


567,916


1,834,380

   Royalty liability


2,403,830


2,385,826

   Lease incentive liability


352,155


342,129

   Capital lease obligation


399,408


582,911

   Deferred revenues, less current portion


1,203,125


964,933

   Deferred income tax liability


220,005


229,579

      Total non-current liabilities


14,458,939


15,839,758

      Total liabilities


27,385,146


30,139,349






Series A 0% Convertible Redeemable Preferred stock, $.01 par
value per share, $8,849,985 redemption value, 4,000,000 shares
authorized, 2,949,995 issued and outstanding, net of
unamortized preferred stock discount of $1,916,350 and
$2,212,007, respectively


6,933,635


6,637,978






Stockholders' equity:





   Common stock, $.01 par value per share, 45,000,000 shares





    authorized, 18,657,974 and 18,553,389 shares issued and





    outstanding, respectively


186,580


185,534

   Additional paid in capital


78,925,512


78,390,424

   Accumulated deficit


(61,440,203)


(59,574,170)

      Total stockholders' equity


17,671,889


19,001,788


$

51,990,670

$

55,779,115

 

STREAMLINE HEALTH SOLUTIONS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)




Three Months Ended April 30,



2015


2014

Operating activities:





  Net loss

$

(1,866,033)

$

(2,671,239)

  Adjustments to reconcile net loss to net cash





used in operating activities:

Depreciation


314,325


150,660

Amortization of capitalized software development costs


782,468


916,868

Amortization of intangible assets


337,230


358,879

Amortization of other deferred costs


59,362


38,838

Valuation adjustment for warrants liability


(1,266,464)


(1,138,021)

Share-based compensation expense


651,982


442,876

Other valuation adjustments


43,412


38,200

Loss on disposal of property and equipment


34,228


-

Provision for accounts receivable


80,086


-

Deferred tax expense


(9,574)


-

  Changes in assets and liabilities, net of effects of acquisitions:





Accounts and contract receivables


551,201


528,680

Other assets


346,036


(927,325)

Accounts payable


(536,076)


(142,824)

Accrued expenses


(117,157)


(378,084)

Deferred revenues


(463,777)


(1,161,803)

  Net cash used in operating activities


(1,058,751)


(3,944,295)






Investing activities:





Purchases of property and equipment


(15,582)


(592,498)

Capitalization of software development costs


-


(193,379)

Payment for acquisition, net of cash received


-


(5,890,402)

  Net cash used in investing activities


(15,582)


(6,676,279)






Financing activities:





Principal repayments on term loan


(125,000)


(202,380)

Principal payments on capital lease obligation


(199,022)


(23,985)

Payment of deferred financing costs


2,111


(112,800)

Proceeds from exercise of stock options and stock purchase plan


143,350


592

  Net cash used in financing activities


(178,561)


(338,573)

Decrease in cash and cash equivalents


(1,252,894)


(10,959,147)

Cash and cash equivalents at beginning of period


6,522,600


17,924,886

Cash and cash equivalents at end of period

$

5,269,706

$

6,965,739

 

STREAMLINE HEALTH SOLUTIONS, INC.

Backlog

(Unaudited)

Table A




April 30,
2015


January 31,
2015


April 30,

2014

Streamline Health Software Licenses

$

25,347,000

$

20,883,000

$

2,006,000

Third Party Hardware and Software


113,000


255,000


54,000

Professional Services


8,046,000


7,485,000


6,948,000

Maintenance and Support


19,616,000


21,297,000


27,114,000

Software as a Service


21,465,000


22,575,000


26,808,000

    Total

$

74,587,000

$

72,495,000

$

62,930,000

 


STREAMLINE HEALTH SOLUTIONS, INC.

New Bookings

(Unaudited)

Table B




Three Months Ended



April 30, 2015



Value


% of Total
Bookings

Streamline Health Software licenses

$

4,736,000


74%

Software as a service


700,000


11%

Maintenance and support


5,000


0%

Professional services


966,000


15%

Hardware & third party software


-


0%

Total bookings

$

6,407,000


100%

 

Reconciliation of Non-GAAP Financial Measures

(Unaudited)

Table C


This press release contains a non-GAAP financial measure under the rules of the U.S. Securities and Exchange Commission for adjusted EBITDA. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally to manage the business, such as in establishing an annual operating budget. Non-GAAP financial measures are used by Streamline Health's management in its operating and financial decision-making because management believes these measures reflect ongoing business in a manner that allows meaningful period-to-period comparisons. Accordingly, the Company believes it is useful for investors and others to review both GAAP and non-GAAP measures in order to (a) understand and evaluate current operating performance and future prospects in the same manner as management does and (b) compare in a consistent manner the Company's current financial results with past financial results. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. The Company's management compensates for these limitations by considering the company's financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. Streamline Health defines "adjusted EBITDA" as net earnings (loss) plus interest expense, tax expense, depreciation and amortization expense of tangible and intangible assets, stock-based compensation expense, significant non-recurring operating expenses, and transactional related expenses including: gains and losses on debt and equity conversions, associate severances and related restructuring expenses, associate inducements, professional and advisory fees, and internal direct costs incurred to complete transactions.


Reconciliation of net earnings (loss) to non-GAAP adjusted EBITDA (in thousands)


Adjusted EBITDA Reconciliation


Three Months Ended,




April 30, 2015


April 30, 2014


Net loss

$

(1,866)

$

(2,671)


    Interest expense


244


169


    Income tax expense


(4)


1


    Depreciation


314


151


    Amortization of capitalized software development costs


782


917


    Amortization of intangible assets


337


359


    Amortization of other costs


43


27


EBITDA


(150)


(1,047)


    Share-based compensation expense


652


443


    Loss of disposal of fixed assets


34


-


    Associate severances and other costs relating to






      transactions or corporate restructuring


140


451


   Non-cash valuation adjustments to assets and liabilities


(1,223)


(1,100)


    Transaction related professional fees, advisory fees and






      other internal direct costs


12


164


    Other non-recurring operating expenses


-


574


    Other non-recurring expenses


(750)


-


Adjusted EBITDA

$

(1,285)

$

(515)

`

Adjusted EBITDA Margin(1)


(21)%


(7)%


Adjusted EBITDA per diluted share






Loss per share - diluted

$

(0.12)

$

(0.16)


Adjusted EBITDA per adjusted diluted share (2)

$

(0.07)

$

(0.03)








Diluted weighted average shares


18,600,957


18,146,232


    Includable incremental shares — adjusted EBITDA (3)


-


-


Adjusted diluted shares


18,600,957


18,146,232


 

(1)

Adjusted EBITDA as a percentage of GAAP revenues

(2)

Adjusted EBITDA per adjusted diluted share for the Company's common stock is computed using the more dilutive of the two-class method or the if-converted method.



(3)

The number of incremental shares that would be dilutive under profit assumption, only applicable under a GAAP net loss. If GAAP profit is earned in the current period, no additional incremental shares are assumed.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/streamline-health-reports-first-quarter-2015-revenues-of-62-million-recurring-revenues-of-93-300096641.html

SOURCE Streamline Health Solutions, Inc.

News Provided by Acquire Media